Ranbaxy Announces Interest In Generics Unit

Indian generics firm Ranbaxy has announced that it will be one of the bidders if German firm Merck KgaA decides to sell its generic drugs division. This makes Ranbaxy the first company to officially express interest in the asset, although other firms such as Israel's Teva have been linked to the move.

To read the full article, please sign in or take a free trial.